You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2010 or most recent year available
Part (ii) Outpatient clients by primary drug and mean age, gender ratio
| Primary drug | Mean age | Gender ratio | |
|---|---|---|---|
| Amphetamines | 31 | 2 | |
| Ecstasy | 27 | 3 |
Notes:
Countries providing data: BE, BG, CZ, DK, EE, IE, GR, ES, FR, IT, CY , LU, HU, MT, NL, AT, PL, RO, SI, SK, FI, SE, UK, HR.
The number of treatment clients in each country is listed in Table TDI-7.
See also 'General notes for interpreting data’ on the Explanatory notes and help page.
Sources:
Reitox national reports 2011 — Standard table 3. See Table TDI-0 for details on sources. See also TDI-5.